GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nexeon MedSystems Inc (OTCPK:NXNN) » Definitions » Total Receivables

Nexeon MedSystems (Nexeon MedSystems) Total Receivables : $2.53 Mil (As of Sep. 2018)


View and export this data going back to 2017. Start your Free Trial

What is Nexeon MedSystems Total Receivables?

Nexeon MedSystems's Total Receivables for the quarter that ended in Sep. 2018 was $2.53 Mil.


Nexeon MedSystems Total Receivables Historical Data

The historical data trend for Nexeon MedSystems's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nexeon MedSystems Total Receivables Chart

Nexeon MedSystems Annual Data
Trend Dec15 Dec16 Dec17
Total Receivables
- 0.22 2.68

Nexeon MedSystems Quarterly Data
Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 2.90 2.68 2.67 2.72 2.53

Nexeon MedSystems Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables


Nexeon MedSystems Total Receivables Related Terms

Thank you for viewing the detailed overview of Nexeon MedSystems's Total Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Nexeon MedSystems (Nexeon MedSystems) Business Description

Traded in Other Exchanges
N/A
Address
10 Jews Street, Ramsbury Site, Charlestown, MA, USA, 33401
Nexeon MedSystems Inc is a neuromodulation medical device manufacturing company. It is engaged in the development and commercialization of its neurostimulation technology platform for the treatment of disorders related to tissues of the nervous system.
Executives
William Rosellini director, 10 percent owner, officer: CHIEF EXECUTIVE OFFICER 2900 N FITZHUGH, SUITE 100, DALLAS TX 75204

Nexeon MedSystems (Nexeon MedSystems) Headlines